Details for New Drug Application (NDA): 204734
✉ Email this page to a colleague
The generic ingredient in FOSRENOL is lanthanum carbonate. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the lanthanum carbonate profile page.
Summary for 204734
Tradename: | FOSRENOL |
Applicant: | Takeda Pharms Usa |
Ingredient: | lanthanum carbonate |
Patents: | 3 |
Pharmacology for NDA: 204734
Mechanism of Action | Phosphate Chelating Activity |
Suppliers and Packaging for NDA: 204734
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FOSRENOL | lanthanum carbonate | POWDER;ORAL | 204734 | NDA | Takeda Pharmaceuticals America, Inc. | 54092-256 | 54092-256-02 | 9 CARTON in 1 PACKAGE (54092-256-02) / 10 POWDER in 1 CARTON (54092-256-01) |
FOSRENOL | lanthanum carbonate | POWDER;ORAL | 204734 | NDA | Takeda Pharmaceuticals America, Inc. | 54092-257 | 54092-257-02 | 9 CARTON in 1 CARTON (54092-257-02) / 10 POWDER in 1 CARTON (54092-257-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 750MG BASE | ||||
Approval Date: | Sep 24, 2014 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 26, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Dec 1, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Dec 1, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 204734
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Takeda Pharms Usa | FOSRENOL | lanthanum carbonate | POWDER;ORAL | 204734-001 | Sep 24, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Takeda Pharms Usa | FOSRENOL | lanthanum carbonate | POWDER;ORAL | 204734-002 | Sep 24, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Takeda Pharms Usa | FOSRENOL | lanthanum carbonate | POWDER;ORAL | 204734-001 | Sep 24, 2014 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription